Everything you need to know about this brand — sourced from our editorial team and the brands we work with.
Why customers choose us
✓Prescription topical medicine containing ruxolitinib
✓JAK inhibitor formulation for topical use
✓Used for selected cases of atopic dermatitis
✓Approved for nonsegmental vitiligo in eligible patients
✓Steroid-free topical formulation
✓1.5% ruxolitinib cream formulation
✓Convenient topical application
✓Product-specific dosage and usage information
✓Clear prescription and safety information
✓Convenient online access through Wellmart.pk
Manufacturer address
1801 Augustine Cut-Off, Wilmington, DE 19803, USA.
Country of manufacture
USA
Got questions?
Frequently asked questions
What is Opzelura?
Opzelura is a prescription topical cream containing ruxolitinib, a JAK inhibitor, used for certain inflammatory skin conditions and nonsegmental vitiligo.
What is the active ingredient in Opzelura?
The active ingredient is ruxolitinib. The current U.S. formulation is ruxolitinib 1.5% cream.
What is Opzelura cream used for?
In the current U.S. prescribing information, Opzelura is indicated for short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in eligible patients and for nonsegmental vitiligo in adults and children 12 years and older.
Is Opzelura used for eczema?
Yes. Opzelura is indicated for mild to moderate atopic dermatitis, commonly known as eczema, in eligible patients.
Is Opzelura used for vitiligo?
Yes. Opzelura is indicated for the topical treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older.
Is Opzelura a steroid cream?
No. Opzelura contains ruxolitinib and is a topical JAK inhibitor rather than a corticosteroid.
How should Opzelura be applied for atopic dermatitis?
The current U.S. prescribing information directs eligible patients to apply a thin layer twice daily to affected areas, subject to the specified body-surface-area and quantity limitations. Follow your prescriber's instructions.
How should Opzelura be applied for nonsegmental vitiligo?
The current U.S. label directs application of a thin layer twice daily to affected areas covering up to 10% of body surface area. Follow the prescribing doctor's instructions.
Can Opzelura be used on the face?
Opzelura may be prescribed for appropriate affected skin areas, including facial areas in certain indications. Use it only as directed by your healthcare professional and avoid contact with the eyes.
Can Opzelura be used around the eyes?
It may be prescribed for appropriate skin around the eye area, but Opzelura should not be placed in the eyes. Follow the specific application instructions provided by your healthcare professional.
Can children use Opzelura?
For atopic dermatitis, the current U.S. labeling includes eligible non-immunocompromised patients 2 years and older. For nonsegmental vitiligo, it is indicated for adults and children 12 years and older.
Can Opzelura be used every day?
Opzelura may be prescribed twice daily for its approved indications, but it is subject to specific duration, body-area, and quantity limitations. Use it exactly as prescribed.
Can Opzelura be used with other JAK inhibitors or biologic medicines?
Combining Opzelura with therapeutic biologics, other JAK inhibitors, or potent immunosuppressants such as azathioprine or cyclosporine is not recommended according to the prescribing information.
Can Opzelura be used inside the mouth or vagina?
No. Opzelura is for topical use on the skin and should not be used in the eyes, mouth, or vagina.
What are the important safety warnings for Opzelura?
Because ruxolitinib is a JAK inhibitor, Opzelura carries important warnings concerning serious infections, mortality, malignancy, major cardiovascular events, and thrombosis. The current label also includes warnings concerning blood-cell abnormalities and other potential risks.
What are common side effects of Opzelura?
Reported adverse reactions vary by indication. For atopic dermatitis, reported reactions include nasopharyngitis, diarrhea, bronchitis, folliculitis, application-site reactions, and others. For nonsegmental vitiligo, reported reactions include application-site acne, itching, redness, nasopharyngitis, headache, and others.
Can Opzelura be used during pregnancy?
Pregnancy-related use should be discussed with a qualified healthcare professional. The prescribing information contains specific pregnancy considerations, so patients should not start or continue Opzelura during pregnancy without medical guidance.